Issue 10/2025
Content (27 Articles)
Utility of [99mTc]Tc-tilmanocept, an immunosuppressive macrophage functional imaging agent in melanoma patients receiving checkpoint inhibitor treatment: a feasibility study
- Open Access
- Checkpoint Inhibitors
- Research
Sarah Boughdad, Sofiya Latifyan, Margret Schottelius, Michael Blue, Stéphanie Tissot, Christine Geldhof, Julien Costes, John O. Prior, Niklaus Schaefer
Real-world treatment practices and survival outcomes of patients with de novo metastatic nasopharyngeal carcinoma after chemoimmunotherapy
- Open Access
- Cytostatic Therapy
- Research
Qin Lin, Yuan Zhou, Lin-Feng Guo, Guan-Zhong Lu, San-Gang Wu
Circ_0074158 and QKI6: A regulatory axis for PD-L1 ubiquitination and immune evasion in NSCLC
- Open Access
- NSCLC
- Research
Haihua Zhang, Xueying Liu, Jie Lei, Feng Tian, Xiaochen Liu, Feng Lv, Shuhong Kang, Ke Lan, Jian Wang, Xiaolong Yan, Yunfeng Ni
Upfront whole blood transcriptional patterns in patients receiving immune checkpoint inhibitors associate with clinical outcome
- Open Access
- Checkpoint Inhibitors
- Research
S. Hone Lopez, S. Loipfinger, A. Bhattacharya, M. Jalving, S. F. Oosting, T. J. N. Hiltermann, M. de Bruyn, E. G. E. de Vries, J. J. de Haan, R. S. N. Fehrmann
Immune checkpoint inhibitors combined with chemotherapy in conversion therapy for stage IV gastric cancer: a multicenter retrospective cohort study
- Open Access
- Gastric Cancer
- Research
Xingmao Huang, Xiangliu Chen, Jiahui Chen, Can Hu, Han Chen, Hang Chen, Jingquan Fang, Zeyao Ye, Yian Du, Pengfei Yu, Ling Huang
Impact of lymph node dissection on survival after neoadjuvant immunochemotherapy for esophageal squamous cell cancer: a double-center real-world retrospective study
- Open Access
- Esophageal Cancer
- Research
Yan Huang, Xirui Lin, Caiyan Fang, Zhichao Li, Jiyang Chen, Xiuying Xie, Hansheng Wu, Hong Yang, Kongjia Luo, Jianhua Fu
The efficacy and safety of disitamab vedotin combined with immune checkpoint inhibitors in metastatic upper tract urothelial carcinoma: a multicenter real-world study
- Open Access
- Checkpoint Inhibitors
- Research
Cheoklong Ng, Taile Jing, Shicheng Yu, Jianjun Ye, Shun Zhang, Zhankui Jia, Qi Tang, Xiaoyi Hu, Minfeng Chen, Weiping Huang, Jitao Wu, Hai Bi, Zejun Yan, Haibo Shen, Wei Xiong, Zheng Liu, Jun Xiao, Tao Zhang, Xuedong Wei, Hailong Hu, Qing Yang, Yichu Yuan, Zhiyang Huang, Wei Xue, Yige Bao, Guoqing Ding, Dan Xia, Jiwei Huang
Dual targeting of solid tumors using cytokine-induced killer cells modified with a CAR anti-tenascin C and a secretable EGFRxCD3 bispecific antibody
- Open Access
- Solid Tumor
- Research
Silvia Zaninelli, Irene Cattaneo, Rut Valgardsdottir, Roberta Frapolli, Ezia Bello, Marina Meroni, Andrea Gianatti, Silvia Panna, Paola Rizzo, Susanna Tomasoni, Maurizio D’Incalci, Martino Introna, Josée Golay, Alessandro Rambaldi
Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation
- Open Access
- Sarcoma
- Brief Report
Raffaella De Maria, Chiara Donini, Sonia Capellero, Annamaria Massa, Federica Galvagno, Alessia Proment, Letizia Vitali, Elisa Vigna, Elisa Landoni, Gianpietro Dotti, Valeria Leuci, Paolo Accornero, Luiza Cesar Conti, Matteo Olimpo, Enrico Berrino, Giovanni Grignani, Anna Sapino, Dario Sangiolo, Luca Aresu
Tertiary lymphoid structures gene signature predicts response to immunotherapy plus chemotherapy in advanced non-small cell lung cancer
- Open Access
- NSCLC
- Research
Wei Du, Bijing Xiao, Xuan Yang, Jianhua Zhan, Haishuang Sun, Yunpeng Yang, Wenfeng Fang, Yan Huang, Dongchen Sun, Shaodong Hong, Li Zhang
GARP-expressing Tregs as a source of immunosuppressive TGF-β1 in human tumors
- Open Access
- Urothelial Cancer
- Research
Pierre Van Meerbeeck, Douae Maatougui, Grégoire de Streel, Noora Vaherto, Etienne Marbaix, Frank Aboubakar Nana, Marc Van den Eynde, Alix Devaux, Javier Carrasco, Agnès Noel, Nicolas van Baren, Sophie Lucas
High baseline PD-1+ CD8 T Cells and TIGIT+ CD8 T Cells in circulation associated with response to PD-1 blockade in patients with non-small cell lung cancer
- Open Access
- NSCLC
- Research
Nikita Dutta, Johanna Svensson, George-Alehandro Saad, Marielle Mello, Ella A. Eklund, Ilayda Altinönder, Per Torstensson, Volkan I. Sayin, Anna Rohlin, Hervé Luche, Andreas Hallqvist, Sukanya Raghavan
High-plex imaging of hepatoblastoma and adjacent liver in pediatric patients reveals a predominant myeloid infiltrate expressing immune-checkpoints
- Open Access
- Cytostatic Therapy
- Research
Daniëlle Krijgsman, Stephanie A. Schubert, Lianne J. Kraaier, Yuyan Lu, Kristof van Avondt, Meggy E. L. Verdonschot, Jeanette H. W. Leusen, Marius C. van den Heuvel, Ruben H. de Kleine, Vincent E. de Meijer, Kathelijne C. J. Kraal, Ronald R. de Krijger, József Zsiros, Weng Chuan Peng, Yvonne Vercoulen
The efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy for locally advanced gastric cancer: a single-center, real-world clinical study
- Open Access
- Gastric Cancer
- Research
Xuan Pan, Huayun Zhu, Xingwang Li, Siwen Liu, Shuchen Dong, Chao Yue, Pingping Wu, Yan Sun
The cGAS-STING pathway is a master regulator of OCT4 expression in persistent sarcoma cells and enhances cellular immunotherapy with NK and CIK lymphocytes
- Open Access
- Sarcoma
- Research
Giorgia Giordano, Alessandra Merlini, Federica Capozzi, Giulio Ferrero, Cristina Tucciarello, Shahab Majidi, Simona Comparato, Giulia Mesiano, Elisabetta Liuzzi, Federica Galvagno, Annamaria Massa, Silvia Brusco, Valeria Leuci, Chiara Riganti, Santina Cutrupi, Michele De Bortoli, Lorenzo D’Ambrosio, Dario Sangiolo, Giovanni Grignani, Ymera Pignochino
Dynamic remodeling of tertiary lymphoid structures in response to cancer therapy: a recent review
- Open Access
- Radiotherapy
- Review
Chongyu Tan, Jinliang Huang, Ning Gao, Bingquan Wu, Matsika Juliet, Jiatong Xiao, Jiao Hu, Ping Liu, Jinbo Chen
Spatially resolved endothelial signaling via nampt-itga5 drives immune evasion in stem-like gastric cancer
- Open Access
- Gastric Cancer
- Research
Ji-Yong Sung, Jae-Ho Cheong, Eui Tae Kim
Nattokinase-driven remodeling of tumor microenvironment enhances the efficacy of MSLN-targeted CAR-T cell therapy in solid tumors
- Open Access
- Solid Tumor
- Research
Lianfeng Zhao, Yan Zhang, Xinhao Yang, Tianyu Chen, Jiaqi Liu, Zhigang Guo
Stress induces corticosterone-mediated CD8+ T cell exhaustion to promote non-small cell lung cancer
- Open Access
- NSCLC
- Research
Qiaoqi Zheng, Ji Zhuoga, Qian Weng, Huijie Zhang, Lingling Deng, Maimaititusun Yalikun, Peng Fu, Zaiquan Dong, Jingcheng Dong
Efficacy and safety of two-year fixed versus continuous immune checkpoint inhibitor therapy in advanced or metastatic non-small cell lung cancer: a systematic review
- Open Access
- Checkpoint Inhibitors
- Review
Toshali Pandey, Sajjad A. Bhatti
The protective role of γδ T cells in endometrial cancer
- Open Access
- Endometrial Cancer
- Research
David P. Mysona, Akash Shah, Natalia Jaeger, Ahmad Almadadi, Brian Orr, Richard McIndoe, Marian Johnson, Robert Higgins, Bunja Rungruang, Sharad Ghamande, Catherine Hedrick, Klaus Ley
Single-cell transcriptomic analyses provide insights into SPP1+ TAM-mediated immune suppression and CD8+ T cell dysfunction in lung cancer
- Open Access
- Lung Cancer
- Research
Rahma Taher Almgrami, Tengyue Zhang, Qitai Zhao, Mingming You, Jinyan Liu, Yi Zhang
Immunotherapy change overcomes acquired resistance after chemo-immunotherapy in unresectable biliary tract cancer
- Open Access
- Checkpoint Inhibitors
- Research
Xiangqi Chen, Zixiang Zhou, Shuofeng Li, Guanhua Yu, Shi Feng, Ze Zhou, Boyu Sun, Shanshan Wang, Kai Liu, Chengjie Li, Mingjian Piao, Mingming Wang, Yihong Zhang, Hu Li, Chengpei Zhu, Zhenyu Zhu, Haitao Zhao
Differentiation and mitochondrial metabolic characteristics of CD8+ T cells in malignant ascites of epithelial ovarian cancer and their correlation with estrogen signaling
- Open Access
- Ascites
- Research
Zouyu Jiang, Ying Zhou, Jiajuan Wu, Yu Shen, Danni Tang, Yuhong Wu, Qiuxia Qu, Juan Wang
Correction: Metastatic sites of baseline as predictors in recurrent or metastatic nasopharyngeal carinoma treated with PD-L1 inhibitor: a secondary analysis of multicenter, single-arm, phase II study (KL-A167)
- Open Access
- Correction
Yuantai Li, Yu Min, Zhigong Wei, Zheran Liu, Yiyan Pei, Yujie Yang, Kun Gao, Ge Song, Shihong Xu, Shuangshuang He, Junyou Ge, Yan Qing, Youneng Wei, Ping Ai, Ye Chen, Xingchen Peng
Correction: Association of lymphocyte subsets percentage with prognosis for recurrent or metastatic nasopharyngeal carcinoma patients receiving PD-L1 inhibitors
- Open Access
- Metastasis
- Correction
Jianming Diao, Zhigong Wei, Yiyan Pei, Junyou Ge, Yan Qing, Youneng Wei, Ye Chen, Xingchen Peng
Immune checkpoint inhibitors-associated acute kidney injury: a systematic review and meta-analysis of incidence, kidney recovery, and recurrent risk
- Open Access
- Acute Kidney Injury
- Review
Cheng-Wei Ho, Nai-Wen Kang, Tzu-Hsuan Yeh, Min-Hsiang Chuang, Wen-Wen Tsai, Hsien-Yi Wang, Vin-Cent Wu, Heng-Chih Pan, Jui-Yi Chen